| Views | |
|---|---|
| Combined use of arginase II inhibitors and tadalafil for the correction of monocrotaline pulmonary hypertension | 95 |
| March 2025 | April 2025 | May 2025 | June 2025 | July 2025 | August 2025 | September 2025 | |
|---|---|---|---|---|---|---|---|
| Combined use of arginase II inhibitors and tadalafil for the correction of monocrotaline pulmonary hypertension | 2 | 1 | 7 | 3 | 8 | 1 | 0 |
| Views | |
|---|---|
| Koklin_Combined.pdf | 55 |
| Views | |
|---|---|
| United States | 40 |
| Canada | 11 |
| Germany | 5 |
| India | 4 |
| Vietnam | 3 |
| Australia | 1 |
| Czech Republic | 1 |
| Egypt | 1 |
| EU | 1 |
| United Kingdom | 1 |
| Views | |
|---|---|
| Ottawa | 11 |
| Houston | 6 |
| Durham | 4 |
| Fairfield | 4 |
| Hanoi | 3 |
| Mumbai | 3 |
| Palo Alto | 3 |
| Mountain View | 2 |
| Asheville | 1 |
| Coburg | 1 |